Professionnels des affaires règlementaires, représentants des autorités de réglementation ou de la société civile et autres professionnels impliqués dans la lutte contre les faux médicaments se réunissent à Dakar dans le cadre d’un séminaire pour discuter d’ une approche intégrée contre les faux médicaments. Dakar (Sénégal) – Un séminaire sur la problématique des faux médicaments...
Read more• Report produced by leading R&D based pharmaceutical companies calls for a coherent, comprehensive and integrated approach at global and national levels to minimize growth of resistance to antibiotics. Preventing resistance requires a joint approach from healthcare professionals, pharmaceutical industry, policy makers and individual citizens to work together to promote appropriate antibiotic use. • Report...
Read moreClick here to listen to the full interview
Read moreIFPMA firmly supports the efforts of governments and civil society to increase access to medicines in developing countries, particularly in LDCs. Ensuring the availability, accessibility, and affordability of medicines is complex, and must be viewed within the overall context of universal health coverage. The vast majority of essential medicines are not protected by intellectual property...
Read morePlus de 150 experts réglementaires de quelques 40 différents pays se réunissent à Dakar, Sénégal. Ils représentent, entre autres, des agences gouvernementales, des organisations multilatérales, l’industrie pharmaceutique, et la société civile pour discuter des moyens permettant d’accélérer la disponibilité des médicaments et vaccins pour les patients en Afrique. Dakar, 27-28 avril 2015 – DIA (Développer,...
Read moreThis IFPMA video illustrates what biotherapeutics are all about. They are typically derived from living organisms and are made by genetically engineering DNA. A high level of precision is required in the commercial manufacturing process to produce a consistent product each time. Every step we take in the production of these medicines requires highly controlled...
Read moreAnalysis of reports over a five year period – from 2005 to 2010 – indicates that counterfeit medicines increased by 122% while diversion and theft increased by 66%. Improvements in surveillance, including detection of security breaches, data collection, analysis, and dissemination are urgently needed to address the public health need to combat the global counterfeit...
Read moreGeneva, 24 April 2015 −A report entitled Innovation for a healthier world – how the research-based vaccine manufacturers are contributing to the Decade of Vaccines Global Vaccine Action Plan (GVAP) shows how the pharmaceutical industry is bringing innovation to close the immunization gap while stressing the importance of reaching the 20% of children who are...
Read moreThis IFPMA video illustrates what biotherapeutics are all about. They are typically derived from living organisms and are made by genetically engineering DNA. A high level of precision is required in the commercial manufacturing process to produce a consistent product each time. Every step we take in the production of these medicines requires highly controlled...
Read more